SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is being discussed alongside concerns about its heavy debt load, rising borrowing costs and whether AI demand and contract backlog can support its financing needs, with HSBCs bearish assessment adding to the pressure. Traders are split between viewing the balance-sheet risks and insider selling as reasons for further downside and arguing that strong demand, the backlog and Nvidia ties make the drop a buying opportunity.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lilly is drawing attention after breaking to a new high, with traders linking the rally to European regulatory backing for its Foundayo obesity pill and broader optimism about its GLP-1 business. Bulls are celebrating the breakout and healthcares defensive appeal, while skeptics point to possible profit-taking, competition from Novo and the upcoming earnings report.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is fueling a heavily bearish conversation, with traders tying its political-proxy appeal to concerns about Trumps approval and the midterms, while questioning the companys business traction. A smaller bullish contingent sees a possible trading bounce and points to the pending TAE fusion deal as a potential pivot.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to elevated crude prices and fears that Middle East shipping or energy-infrastructure attacks could disrupt supply, while weighing possible diplomacy and Russian supply relief. The community is split between bulls focused on geopolitical risk and bears expecting the risk premium to fade, with some also warning that contract-roll effects and an extended run may amplify volatility.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers rally to a 52-week high is driving discussion, with traders citing momentum and rotation into defensive, dividend-paying pharma amid broader market weakness. Bulls see a potential breakout, while skeptics point to resistance and say a fresh company-specific catalyst is needed.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, drawing attention to the drugs potential but also to concerns about modest symptom improvement, agitation-related side effects, and discontinuations. Traders are divided, with some viewing the move as a fading bounce and adding shorts while others point to bullish analyst commentary.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is drawing attention after strong Q3 results and an upbeat outlook, with AI-related demand and growing Vertical Power Delivery royalty revenue reinforcing the growth story. Traders are weighing that strength against questions about one-time royalty catch-up payments, production capacity, and the earnings-per-share miss, contributing to a volatile reaction.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces quarterly results beat expectations and the company raised its outlook, but shares fell as traders weighed rising costs, weaker cash flow and a loss in its insurance business. The reaction has split the community between buyers calling the selloff unjustified after a strong report and bears focused on the cost pressures and weak price action.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is in focus amid volatile swings tied to a tech and AI-led selloff followed by a relief rebound. Traders disagree over whether the bounce can hold or is a bull trap, while concerns about AI funding and hedge-fund selling, rising oil and inflation, and upcoming megacap earnings add to uncertainty.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings and revenue beat and a new multiyear buyback, as traders focus on the narrowed profit outlook with its midpoint unchanged and declining U.S. sales and market share. Some see the decline as a buying opportunity given cash generation and capital returns, while others argue the outlook failed to justify the valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nano Dimension (NNDM) Issues Update on Infinite Epigenetics Combination

Nano Dimension (NNDM) Issues Update on Infinite Epigenetics Combination...

Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign

Others

Nano Dimension Ltd. (Nasdaq: NNDM) (Nano Dimension, Nano, or the Company) today issued the following letter to shareholders regarding its upcoming Extraordinary General Meeting (EGM) scheduled for July 31, 2026. Nano's Board of Directors (the Board) urges shareholders to carefully evaluate its...

Wednesday Sector Leaders: Computers, Biotechnology Stocks

In trading on Wednesday, computers shares were relative leaders, up on the day by about 5.6%. Leading the group were shares of AstroNova, up about 70.2% and shares of Nano Dimension Ltd (NNDM) up about 9.8% on the day.

Also showing relative strength are biotechnology shares, u...

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nanos announcement that...

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?

Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, Murchinson or we), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) (Nano or the Company), today issued the following letter to Nano...

Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company

Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, Murchinson or we), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) (Nano or the Company), today announced it will host an investor conference...

Nano Dimension Issues Letter to Shareholders

This account has been verified as an official NNDM representative.

Verified Account

Nano Dimension

Nano Dimension Ltd. engages in the provision of intelligent machines for the fabrication of additively manufactured electronics. Its products include DragonFly IV, AME Materials, Fabrica 2.0, Fabrica Micro-AM Materials, Essemtec SMT Equipment, and Global Inkjet System. The company was founded by Amit Dror and Simon Anthony-Fried in 2012 and headquartered in Ness Ziona, Israel.

Nano Dimension Ltd - ADR

NNDM Stock In Focus: Nano Dimension Pops A Poison Pill Days After Oramed Stake Build-Up

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Nano Dimension will issue rights to ADR holders that will allow them to buy more ADRs if a person or entity builds a 9.99% or more stake in the company without&nbsp;the board’s approval.</li><li>Nano Dimension has been undergoing a restructuring since last year, under a new CEO and management.</li><li>Stocktwits sentiment for NNDM was ‘neutral.’</li></ul>Nano Dimension Ltd. on Monday said the 3D printing technology company has adopted a limited duration shareholder rights agreement, also known as “poison pill,” intended to protect the long-term interest of the company and its shareholders.The agreement will encourage anyone seeking a significant interest in the company to negotiate directly with the board before attempting to gain control or significant influence, Nano Dimension said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/nano-dimension-adopts-limited-duration-233000411.html">statement</a>.<h2 class="st-heading-2">Poison Pill Plan</h2>As per the plan, the company will issue one special purchase right for one American Depository Receipt held on Feb. 13. The contract will give the right for its holder to acquire one Nano Dimension U.S.-listed stock for $0.01, and will be exercisable if an entity, person or group acquires 9.99% or more of Nano Dimension’s outstanding shares in a transaction or transactions not approved by the company’s board.The so-called poison pill is a corporate defence that makes hostile takeovers prohibitively expensive by allowing existing shareholders to buy shares at a discount, diluting the bidder’s stake.Nano Dimension did not identify any entity or person whose actions prompted it to adopt the plan.&nbsp;<h2 class="st-heading-2">Oramed Pharma, CEO Build Stake</h2>Last week, Oramed Pharmaceuticals Inc. and its CEO, Nadav Kidron, disclosed that they had built up a 5% in Nano Dimension, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/1643303/000121390026009570/xslSCHEDULE_13D_X01/primary_doc.xml">securities filing</a>. They intend to actively engage with management, the board, and shareholders to push for strategic, governance, and board-level changes&nbsp;to improve performance and shareholder value, according to the filing.Oramed is an Israeli-U.S. biotech company best known for developing an oral insulin capsule to treat diabetes and pioneering technology to enable oral delivery of drugs normally given by injection.<h2 class="st-heading-2">Nano Dimension’s Restructuring</h2>Founded in Israel and now headquartered in Waltham, Massachusetts, Nano Dimension provides additive manufacturing (AME) and precision 3D-printing systems that let customers design and produce high-performance electronic devices and complex mechanical parts in-house.The company is undergoing a major restructuring to achieve profitability, led by a new board and senior management, including CEO Ofir Baharav, who took charge in early 2025.<a href="https://stocktwits.com/symbol/NNDM">Nano Dimension stock</a> is up 22% so far this year. It dropped 38% over 2025. The Stocktwits sentiment for NNDM remained ‘neutral,’ unchanged from the previous day.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Nano Dimension logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The poison pill is a corporate defence that makes hostile takeovers prohibitively expensive.

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$1.43
Prev Close	$1.42
Open	$1.42
Dividend Yield	0.00%
50-Day Moving Average	$1.56
Beta	0.98
Avg. Volume	1.81M
PE Ratio	-1.82

52-Week High	$2.32
52-Week Low	$1.19
Market Capitalization	$299.04M
EPS (Annual)	-$1.37
Price to Book	0.62
Revenue Per Employee	$220,618.87

Feed

News

Sentiment

Earnings

Fundamentals

Info

NNDM Fundamentals